- 2026-12-04
-
Sequential cisplatin–navitoclax therapy exploits an evolutionary vulnerability to delay recurrence in epithelial ovarian cancer
18:16-18:23
Room 503
Mini Oral
Speaker

Lin Huang
Sequential cisplatin–navitoclax therapy exploits an evolutionary vulnerability to delay recurrence in epithelial ovarian cancer
18:16-18:23
Room 503
Mini Oral
Speaker